LAUREN SHINA: Open Payments
NPI 1972219939 · ROYAL OAK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,036 in 98 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $470 · 2025 $2,036
Food & beverage: $2,002Education: $34
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 24 | $525 |
| Amgen Inc. | 11 | $197 |
| Optinose US, Inc. | 7 | $180 |
| GlaxoSmithKline, LLC. | 14 | $166 |
| Regeneron Healthcare Solutions, Inc. | 7 | $162 |
| CSL Behring | 6 | $152 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $115 |
| GENZYME CORPORATION | 5 | $99 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $55 |
Products named: TEZSPIRE, AIRSUPRA, DUPIXENT, Xhance, XOLAIR, FASENRA, TRELEGY ELLIPTA, Andembry.
Industry payments across MI — which companies pay providers there.
